BIOMERICA INC (BMRA)

AI-Powered SEC Filing Analysis

Quarterly Report Filed: 2026-04-13

Key Insights

The company reported a significant increase in sales revenue concentrated among a few key customers in the Middle East, Asia, and Europe regions over the past year.
The company's cost of goods sold was highly concentrated with a few key vendors, indicating potential supply chain risks.
The company made notable investments in intangible assets such as marketing/distribution rights, purchased technology, and patents, suggesting a focus on product development and expansion.

Insider Trading Filed: 2026-01-28

Key Insights

Eric Chin, a director of Biomerica Inc, has been awarded 22,500 shares of restricted stock under the company's 2024 Stock Incentive Plan. This indicates Chin's increased ownership stake and alignment with shareholders.
The restricted stock award will vest fully after one year, provided Chin remains in continuous service, suggesting the company's confidence in his continued contributions.
Insider buying, such as this restricted stock award, can be a positive signal for investors, as it may indicate management's belief in the company's future prospects.

Quarterly Report Filed: 2026-01-14

Key Insights

The company reported a significant increase in sales revenue from key customers in Asia, North America, and the Middle East during the third quarter of 2025 compared to the prior year period.
The company's accounts receivable balances from its four key customers in Asia, North America, Europe, and the Middle East have grown substantially over the past year, indicating potential liquidity and working capital challenges.
The company's cost of goods sold is highly concentrated with one key vendor and two other vendors, exposing it to supplier concentration risk that could impact margins.

Insider Trading Filed: 2025-12-31

Key Insights

Insider David Moatazedi acquired 20,000 shares of Biomerica Inc (BMRA) through a restricted stock award, indicating his confidence in the company's future performance.
The restricted stock award is subject to a one-year vesting period, aligning Moatazedi's interests with long-term shareholders.
The insider transaction is relatively small in size, representing a minor increase in Moatazedi's direct ownership stake in the company.

Insider Trading Filed: 2025-12-31

Key Insights

The reporting person, Gary M. Huff, acquired 20,000 shares of common stock of BIOMERICA INC (BMRA) on December 12, 2025 as an award of restricted stock under the company's 2024 Stock Incentive Plan.
The restricted stock award will vest in full on the one-year anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the issuer.
This acquisition of equity securities by a director of the company could signal their confidence in the company's future prospects and alignment with shareholder interests.

Insider Trading Filed: 2025-12-31

Key Insights

The reporting person, Allen Barbieri, who is the Executive Vice-Chairman of Biomerica Inc., acquired 30,000 shares of the company's common stock on December 12, 2025 under the 2024 Stock Incentive Plan. This suggests his continued commitment and confidence in the company's future.
The reporting person's total beneficial ownership of Biomerica's common stock increased to 53,543 shares following this transaction, indicating his substantial stake in the company.
The restricted stock award is subject to a one-year vesting period, aligning the reporting person's interests with those of long-term shareholders.

Insider Trading Filed: 2025-12-31

Key Insights

Zackary S. Irani, the Chief Executive Officer of Biomerica Inc (BMRA), acquired 52,500 shares of the company's common stock through a restricted stock award, indicating his confidence in the company's future performance.
The restricted stock award will vest over 4 years, aligning Irani's interests with those of long-term shareholders and suggesting his commitment to the company's long-term success.
Insider buying, especially by the CEO, is generally viewed as a positive signal for investors, as it suggests management's belief in the company's growth potential.

Insider Trading Filed: 2025-12-31

Key Insights

The reporting person, Gary Lu, was awarded 40,000 shares of restricted stock under the 2024 Stock Incentive Plan, which will vest over 4 years at 25% per year as long as he remains in continuous service.
This insider grant indicates that the company is incentivizing key management to drive long-term value, which could be a positive sign for investors.
The reporting person's direct ownership of 59,375 shares after the transaction suggests he has a significant stake in the company's performance, aligning his interests with shareholders.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.